Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS005 in Chinese Adults With Active Non-radiographic Axial Spondyloarthritis
NCT05242588Phase 2Terminated
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of roconkibart in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by Shanghai Junshi Biosciences Co., Ltd.. Started Dec 2021; status: terminated.
02
Drugs
roconkibart
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT05242588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05242588.